Efficacy and Sustainability of a Carepartner-Integrated Telerehabilitation Program for Persons With Stroke
Launched by EMORY UNIVERSITY · Oct 22, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new online program designed to help both stroke survivors and their family members or caregivers work together during rehabilitation. The program, called CARE-CITE, focuses on teaching caregivers problem-solving skills while supporting stroke survivors as they practice daily activities at home. The goal is to create a more effective and supportive rehabilitation process that benefits both the person recovering from a stroke and their caregiver.
To participate in this study, caregivers must be at least 18 years old, live with the stroke survivor, and be able to read and write in English. Stroke survivors need to be over 18, between 3 months and 2 years after their stroke, and should be able to perform some basic movements with their arms and hands. Both caregivers and stroke survivors must have a good understanding of their surroundings, as indicated by a cognitive test score. Participants can expect to engage in the program together, which aims to enhance their skills and support each other on the path to recovery.
Gender
ALL
Eligibility criteria
- CarePartners (CP):
- Inclusion Criteria:
- • Must be at least18 years old,
- • Able to read and write English,
- • Mini-mental test score greater than 24
- • Individuals who are a spouse/partner or family member dwelling in the same household and self-identify as the primary caregiver of the SS.
- Stroke Survivors (SS):
- Inclusion Criteria:
- • Must be at least18 years old
- • More than 3 months and less than 2yrs post-ischemic or hemorrhagic event
- • Discharged home from the hospital with minimal to moderate UE deficits (can actively initiate 20 degrees of wrist and 10 degrees of finger extension)
- • Mini-mental test greater than 24
- • No physician determined medical problems that would limit participation,
- • Must have CP living in the home
- Exclusion Criteria for CP and SS:
- • Significant cognitive deficits
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Sarah Blanton, PT, DPT
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported